# Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study

Study · id `cardio:ct-nct02738749` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02738749](<https://clinicaltrials.gov/study/NCT02738749>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02738749

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.

## Technical summary

Registry record NCT02738749. Allocation not applicable; no masking; primary purpose other. Start 2014-06 (registry gives no type); primary completion 2019-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 450 participants (planned count; ClinicalTrials.gov record NCT02738749, source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02738749, source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)
- Primary completion: 2019-07 (anticipated) (ClinicalTrials.gov record NCT02738749, source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)
- Completion: 2020-07 (anticipated) (ClinicalTrials.gov record NCT02738749, source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02738749, source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02738749-2017-04-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sodium Channel Splicing in Heart Failure Trial (SOCS-HEFT) Prospective Study
- Condition: Death, Sudden, Cardiac
- Intervention (Device): Implantable cardioverter-defibrillator (ICD)
- Lead sponsor: Rhode Island Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Implantable cardioverter-defibrillator (ICD) (`cardio:implantable-cardioverter-defibrillator`)
- Registry lists this organization as the lead sponsor: Rhode Island Hospital (`cardio:org-rhode-island-hospital`)

## Provenance

Content hash: 59d4f1485e8a043d923788e986709efbdeeb8f5fd0b1f41eec32752c9da5c14e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
